One site for Breaking News, Politics, Sports, Entertainment & more!

Newz Chooze
Back

Gossamer Bio will go public Friday on the Nasdaq. Shares priced at $16 apiece on Thursday evening, raising about $276 million. Gossamer will trade under the ticker "GOSS."  Gossamer Bio priced its initial public offering on Thursday evening.  The clinical-stage biopharmaceutical company that focuses on "discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology" priced its IPO at $16 a share, according to a press release out Thursday evening. The sale of 17.25 million shares will raise about $276 million.  BofA Merrill Lynch, SVB Leerink, Barclays and Evercore ISI were  joint book-running managers for the offering. Gossamer shares will trade on the Nasdaq, under the ticker "GOSS."  Join the conversation about this story » NOW WATCH: Roger Stone explains what Trump has in common with Richard Nixon